T1	Pharmacological_substance 17 27	mexiletine
N1000 	Reference T1 MeSH:D008801	mexiletine
T4	Pharmacological_substance 52 62	tizanidine
N1001 	Reference T4 MeSH:C023754	tizanidine
T5	Pharmacological_substance 152 162	mexiletine
N1002 	Reference T5 MeSH:D008801	mexiletine
T8	Pharmacological_substance 237 247	tizanidine
N1003 	Reference T8 MeSH:C023754	tizanidine
T9	Pharmacological_substance 274 284	tizanidine
N1004 	Reference T9 MeSH:C023754	tizanidine
T10	Pharmacological_substance 372 382	tizanidine
N1005 	Reference T10 MeSH:C023754	tizanidine
T12	Pharmacological_substance 407 417	mexiletine
N1006 	Reference T12 MeSH:D008801	mexiletine
T14	Pharmacological_substance 530 540	tizanidine
N1007 	Reference T14 MeSH:C023754	tizanidine
T15	Pharmacological_substance 548 558	mexiletine
N1008 	Reference T15 MeSH:D008801	mexiletine
T19	Pharmacological_substance 766 776	tizanidine
N1009 	Reference T19 MeSH:C023754	tizanidine
T23	Pharmacological_substance 943 953	tizanidine
N1010 	Reference T23 MeSH:C023754	tizanidine
T24	Pharmacological_substance 1024 1034	mexiletine
N1011 	Reference T24 MeSH:D008801	mexiletine
T26	Pharmacological_substance 1080 1090	tizanidine
N1012 	Reference T26 MeSH:C023754	tizanidine
T27	Pharmacological_substance 1095 1105	mexiletine
N1013 	Reference T27 MeSH:D008801	mexiletine
T28	Pharmacological_substance 1118 1128	tizanidine
N1014 	Reference T28 MeSH:C023754	tizanidine
T29	Disorder 1176 1185	dry mouth
N1 	Reference T29 UMLS:C0043352	dry mouth
T30	Pharmacological_substance 1272 1282	mexiletine
N1015 	Reference T30 MeSH:D008801	mexiletine
T31	Pharmacological_substance 1299 1309	tizanidine
N1016 	Reference T31 MeSH:C023754	tizanidine
T32	Pharmacological_substance 1338 1348	tizanidine
N1017 	Reference T32 MeSH:C023754	tizanidine
T33	Disorder 1378 1405	reduction in blood pressure
N2 	Reference T33 UMLS:C0232107	reduction in blood pressure
T7	Subject 1055 1066	15 patients
T11	Disorder 1410 1426	adverse symptoms
T35	Subject 325 348	12 healthy participants
T36	Disorder 1137 1152	adverse effects
N3 	Reference T36 UMLS:C0879626	adverse effects
T37	Disorder 1161 1171	drowsiness
N4 	Reference T37 UMLS:C2830004	drowsiness
T45	Combination 559 575	coadministration
T49	Combination 1004 1020	coadministration
T52	Combination 1252 1268	coadministration
T56	Combination 1091 1094	and
T57	Subject 1107 1108	4
